Diclofenac Sodium And Misoprostol
NDC Package 69339-124-06

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Diclofenac Sodium And Misoprostol is a . Marketed by Dash Pharmaceuticals Llc, this product is identified by NDC 69339-124 and is authorized under FDA application ANDA200540.

Identification & Billing

NDC Package Code
69339-124-06
Package Description
60 TABLET, DELAYED RELEASE in 1 BOTTLE
Product Code
69339-124
11-Digit Billing Format
69339012406
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
60 EA

Clinical Specifications

Proprietary Name
Diclofenac Sodium And Misoprostol Delayed-release
Dosage Form
-

Regulatory & Marketing

Labeler Name
Dash Pharmaceuticals Llc
FDA Application #
ANDA200540
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
01-23-2015
End Marketing Date
08-31-2019
Listing Expiration
08-31-2019
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 69339-124-06 identifies a specific commercial package of 60 tablet, delayed release in 1 bottle of Diclofenac Sodium And Misoprostol Delayed-release, labeled by Dash Pharmaceuticals Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Dash Pharmaceuticals Llc on January 23, 2015. The current certification is valid through August 31, 2019.

How is this Dash Pharmaceuticals Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 69339012406. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 60 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
69339-124-06
11-Digit CMS (5-4-2)
69339-0124-06

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.